サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1212520

バイオテクノロジー関連機器の世界市場

Biotechnology Instrumentation
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 246 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
バイオテクノロジー関連機器の世界市場
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 246 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

バイオテクノロジー関連機器の世界市場は2030年に674億米ドルに達する

変化したCOVID-19後のビジネス環境において、2022年に434億米ドルと推定されるバイオテクノロジー関連機器の世界市場は、2030年までに674億米ドルの改定規模に達し、分析期間2022-2030年に5.7%のCAGRで成長すると予測されます。本レポートで分析したセグメントの1つである免疫測定システムは、CAGR4.7%を記録し、分析期間終了時には238億米ドルに達すると予測されます。パンデミック後の回復を考慮し、DNAシーケンシングシステム分野の成長は、今後8年間のCAGRを7.9%に修正する予定です。

米国市場は127億米ドル、中国はCAGR5.3%で成長すると予測されています。

米国のバイオテクノロジー関連機器市場は、2022年に127億米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが5.3%で、2030年には119億米ドルの市場規模に達すると予測されています。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ4.9％と4.8％の成長が予測されています。欧州では、ドイツがCAGR約4.4%で成長すると予測されています。

調査対象企業の例

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • GE HealthCare（UK）
  • Gilson Inc.
  • Harvard Bioscience Inc.
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Lonza Group AG
  • PerkinElmer Inc.
  • Roche Diagnostics
  • Shimadzu Corp.
  • Siemens Healthineers
  • Thermo Fischer Scientific Inc.
  • Waters Corp.）

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP-3504

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Biotechnology Instrumentation Market to Reach $67.4 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Biotechnology Instrumentation estimated at US$43.4 Billion in the year 2022, is projected to reach a revised size of US$67.4 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2022-2030. Immunoassay Systems, one of the segments analyzed in the report, is projected to record a 4.7% CAGR and reach US$23.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the DNA Sequencing Systems segment is readjusted to a revised 7.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $12.7 Billion, While China is Forecast to Grow at 5.3% CAGR

The Biotechnology Instrumentation market in the U.S. is estimated at US$12.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.9 Billion by the year 2030 trailing a CAGR of 5.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 4.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Select Competitors (Total 147 Featured):

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • GE HealthCare (UK)
  • Gilson Inc.
  • Harvard Bioscience Inc.
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Lonza Group AG
  • PerkinElmer Inc.
  • Roche Diagnostics
  • Shimadzu Corp.
  • Siemens Healthineers
  • Thermo Fischer Scientific Inc.
  • Waters Corp.)

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Biotechnology Tools - Driven by Advancements
    • Recent Market Activity
    • Global Market Analysis
    • Factors Sustaining Market Growth
    • Factors Restraining Growth
    • Improving Economy Signals Market Growth Opportunities
    • Biotechnology Instrumentation - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • Abbott Laboratories (USA)
    • Agilent Technologies, Inc. (USA)
    • Beckman Coulter, Inc. (USA)
    • Bio-Rad Laboratories, Inc. (USA)
    • Bruker Corporation (USA)
    • GE HealthCare (UK)
    • Gilson, Inc. (USA)
    • Harvard Bioscience, Inc. (USA)
    • Hitachi High-Technologies Corp. (Japan)
    • Illumina, Inc. (USA)
    • Lonza Group AG (Switzerland)
    • PerkinElmer, Inc. (USA)
    • Roche Diagnostics (Switzerland)
    • Shimadzu Corp. (Japan)
    • Siemens Healthineers (USA)
    • Thermo Fisher Scientific, Inc. (USA)
    • Waters Corp. (USA)
  • 3. MARKET TRENDS & DRIVERS
    • DNA Sequencing
    • Future Diagnostic Applications of DNA Sequencing
    • Next-Generation Sequencing Technologies Drive the Momentum
    • Liquid Chromatography
    • Growth in New Application Markets
    • HPLC Offers Significant Growth Opportunities
    • Innovative HPLC Products Inject New Growth
    • Ultra-High Pressure Liquid Chromatography
    • MS Systems with UHPLC
    • Advancements in HPLC Columns
    • Electrophoresis Systems
    • Capillary Gel Electrophoresis - Gains Prominence
    • Product Innovations Sustain Sales
    • Immunoassay Instruments
    • Growth Opportunities and Areas
    • Automated Multiplexing Platforms Present Growth Opportunities
    • Radioimmunoassay Systems Lose Ground
    • Chemiluminescence Immunoassays Gain Demand
    • Mass Spectrometry
    • Technological Developments and Expanding End-Use Applications to Bolster Growth
    • A Review for Select MS Technologies
    • Portability: A Major Driving Force for MS Systems Market
    • Nanotube Coating to Enable Miniaturization in Mass Spectrometers
    • High Prices of MS Systems Hold Down Sales Growth
    • Purpose-Built Mass Spectrometers to Transform Personalized Medicine
    • Lack of Suitable Software and Diversity of MS Systems - A Major Challenge
    • Smaller Clinical Laboratories Continue to Shy Away from Mass Spectrometers
    • Microarrays
    • Protein Biochips - Set for Robust Expansion
    • Lab-on-a-Chip: Fusion of Nanotechnology & Genetic Engineering
    • Advancements in Biochip Technology
    • Biochip Technology Boosts Personalized Medicine
    • Biochip Technology Spreads beyond Pharma Industry
    • Data on Specificity of Effect Drives Use of Microarrays in Cosmetics and Personal Healthcare
    • Laboratory Automation
    • Technology Sets the Momentum for Microplate Reader Market
    • Growing Options in Multimode Microplate Readers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Biotechnology Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Biotechnology Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for DNA Sequencing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for DNA Sequencing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for DNA Sequencing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 12: World 18-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for MicroArrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for MicroArrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 15: World 18-Year Perspective for MicroArrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Liquid Chromatography Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Liquid Chromatography Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 18: World 18-Year Perspective for Liquid Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Laboratory Automation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Laboratory Automation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 21: World 18-Year Perspective for Laboratory Automation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Electrophoresis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Electrophoresis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 24: World 18-Year Perspective for Electrophoresis Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Product Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Product Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 27: World 18-Year Perspective for Other Product Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 28: World Biotechnology Instrumentation Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 31: USA 18-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 34: Canada 18-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2023 & 2030
  • JAPAN
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 37: Japan 18-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2023 & 2030
  • CHINA
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 40: China 18-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2023 & 2030
  • EUROPE
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Biotechnology Instrumentation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 43: Europe 18-Year Perspective for Biotechnology Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 46: Europe 18-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2023 & 2030
  • FRANCE
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 47: France Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: France Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 49: France 18-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2023 & 2030
  • GERMANY
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Germany Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 52: Germany 18-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 53: Italy Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Italy Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 55: Italy 18-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 56: UK Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: UK Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 58: UK 18-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 59: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Rest of Europe Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 61: Rest of Europe 18-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 64: Asia-Pacific 18-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2023 & 2030
  • REST OF WORLD
    • TABLE 65: Rest of World Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Rest of World Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 67: Rest of World 18-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2012, 2023 & 2030

IV. COMPETITION